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To help elucidate the immunopathogenesis of feline leukemia virus (FeLV)-induced immunodeficiency we studied the
tropism of viruses derived from the FeLV-FAIDS isolate for lymphocyte subpopulations in cats. FeLV-FAIDS is composed
of a replication-competent virus typical of subgroup A FeLV (prototype, clone 61E) and a family of replication-defective but
immunopathogenic variant viruses (prototype, clone 61C). We sorted CD4/, CD8/, and IgG/ lymphocytes to ⁄97% purity
and analyzed viral load in each cell population via genome-specific semiquantitative PCR. Both the 61E and 61C viruses
were tropic for CD4/ and CD8/ T cells as well as IgG/ B lymphocytes in blood and lymph node. High provirus burden
were established for both virus genomes—ranging from 0.3 to 2 copies/cell. To identify the fraction of circulating cells
which expressed viral antigen in vivo, we developed a flow cytometric method to simultaneously label blood leukocytes for
surface immunophenotype and intracytoplasmic FeLV CA (p27 Gag). These experiments established that 20 to 60% of
CD4/, CD8/, and IgG/ lymphocytes and 85% of monocytes and granulocytes expressed FeLV p27 intracellularly. Thus
the in vivo target cells for FeLV-FAIDS infection are manifold and include CD4/ and CD8/ T cells, B cells, and myeloid
cells. q 1996 Academic Press, Inc.
INTRODUCTION lymphomas are virus productive and composed of T cells,
including CD4/, CD8/, and CD4//CD8/ phenotypes
Identification of viral target cells in vivo is prerequisite
(Rojko et al., 1989).
to understanding pathogenesis of retrovirus-induced dis-
Despite its association with lymphomagenesis, severe
eases. Cells infected by the feline leukemia virus (FeLV)
immunosuppression and hematologic suppression are
have been identified by morphology and immunofluores-
perhaps the most frequent manifestations of FeLV infec-
cence of FeLV CA (p27 Gag) expression in lymph nodes,
tion, often contributing to fatal wasting or opportunistic
bone marrow, spleen, and certain glandular and mucosal
infection syndromes and (Anderson et al., 1971, Hardy,
epithelium (Hardy et al., 1973; Hoover et al., 1987; Rojko
1980) erythroid hypoplasias (Anderson et al., 1971;
et al., 1978; Rojko et al., 1979). Whereas FeLV infection
Hardy, 1980; Hoover et al., 1974; Jarrett et al., 1984). Both
is associated with T cell dysfunction in cats (Anderson
proliferative and degenerative FeLV diseases have been
et al., 1971; Cockerell et al., 1976; Diehl and Hoover,
associated with the generation of variant viruses due to
1992; Hoover et al., 1973; Perryman et al., 1972; Quacken-
mutational events in the LTR or env (Neil et al., 1991).
bush et al., 1990; Tompkins et al., 1989; Trainin et al.,
Duplication of the LTR enhancer region is commonly ob-
1983; Wernicke et al., 1986), viral antigens have been served in proviruses isolated from FeLV-positive tumors
detected chiefly within the follicular germinal centers of (Fulton et al., 1990; Matsumoto et al., 1992). Mutations
lymph node and spleen (B cell areas) and to lesser de- in env, particularly within the vr1 and vr5 domains are
gree in the paracortical (T cell) regions (Rojko et al., associated with degenerative FeLV diseases (Brojatsch
1979). Studies employing in vitro infection of feline lymph et al., 1992; Donahue et al., 1988, 1991; Overbaugh et al.,
node and blood mononuclear cells have likewise impli- 1988; Quackenbush et al., 1990; Reidel et al., 1988; Rigby
cated complement receptor bearing B cells as the princi- et al., 1992). We have studied an FeLV isolate associated
pal FeLV replicating cell, whereas little infectious virus with both immunodeficiency and lymphoma (FeLV-
or viral antigen were demonstrable in purified T cells FAIDS) with the intent of elucidating mechanisms of non-
(Rojko et al., 1981). Nevertheless, most FeLV-induced neoplastic FeLV disease (Hoover et al., 1987; Mullins et
al., 1986). FeLV-FAIDS is composed of two major virus
genotypes: (1) a replication-competent interference sub-1 Present address: Department of Microbiology and Immunology,
College of Veterinary Medicine, Cornell University, Ithaca, NY 14853- group A virus (Sarma and Log, 1971) (represented by the
6401. molecular clone 61E), and a family of closely related2 Present address: Department of Medicine and Epidemiology,
variant viruses (represented by the molecular clone 61C,School of Veterinary Medicine, University of California, Davis, CA 95616.
obtained from the same animal and tissue as 61E) (Over-3 To whom correspondence and reprint requests should be ad-
dressed. Fax: (970) 491-0523. E-mail: ehoover@lamar.colostate.edu. baugh et al., 1988). Eleven amino acid substitutions, a
1
0042-6822/96 $18.00
Copyright q 1996 by Academic Press, Inc.
All rights of reproduction in any form reserved.
AID VY 8072 / 6a1c$$$361 08-02-96 11:20:07 vira AP: Virology
2 QUAKENBUSH ET AL.
six amino acid deletion (18-bp deletion), and six amino Membrane fluorescence labeling and cell sorting
acid insertion (18-bp insertion) distinguish the variant
Two to 10 million PBMC or lymph node cells were61C envelope surface glycoprotein (SU) from that of 61E
added to microfuge tubes and washed with 1 ml PBS(Donahue et al., 1988; Overbaugh et al., 1988). These
containing 2% fetal calf serum and 0.02% sodium azidesubstitutions in the 61C SU impart T cell cytopathicity in
(PBS/FCS/NaN3). Monoclonal or affinity-purified poly-vitro and acute immunopathogenicity in vivo (Donahue
clonal antibody (25 ml/106 cells) was added to each tubeet al., 1991; Quackenbush et al., 1990).
and incubated for 20 min at 47. Cells were washed twoWhile the variety of tissues that support FeLV-FAIDS
times with PBS/FCS/NaN3 . Fifty microliters of either goatreplication appears similar to those of previously de-
anti-mouse IgG fluorescein isothiocyanate (Kirkegaardscribed FeLV strains (Hoover et al., 1987), the lymphoid
and Perry Lab. Inc., Gaithersburg, MD) or mouse anti-cell subpopulations targeted by this and other FeLVs in
goat IgG fluorescein isothiocyanate (Kirkegaard andvivo have yet to be definitively identified. In the present
Perry Lab. Inc., Gaithersburg, MD) were added to eachstudy we use cell sorting, semiquantitative PCR, and two-
tube, incubated for 20 min at 47 and washed as describedcolor surface and intracellular immunostaining and flow
above. Cells were resuspended to 3 1 106 cells/ml incytometry to examine the lymphocyte subsets infected
lymphocyte medium and placed on ice. Cells were fil-by the FeLV-FAIDS 61E and 61C viruses in vivo.
tered through a 20-mm nylon mesh before sorting. The
anti-feline CD4 and CD8 monoclonal antibodies, 7G4.1
and 31B.5 (O’Reilly and Hoover, 1993) and an affinity-MATERIALS AND METHODS
purified polyclonal goat anti-cat IgG antibody (Kirkegaard
and Perry Lab. Inc., Gaithersburg, MD) were used inAnimals and virus inoculation
these experiments.
Thirty-four 5- to 12-week-old cats from the breeding Fluorescent cells were sorted with an EPICS C flow
colony in the Department of Pathology, Colorado State cytometer (Coulter Electronics, Hialeah, FL) equipped
University, and from Liberty Laboratories (Liberty Cor- with a 2-W argon laser with an 488-nm excitation wave-
ner, NJ) were anesthetized with ketamine hydrochlo- length. A bitmap gate set on a forward light scatter versus
ride (25 mg/kg) and injected either intraperitoneally or log side scatter histogram was used to identify the lym-
intravenously with 5 1 103 infectious units (Fischinger phocyte population. Sorting logic was based on the log
et al., 1974) of FeLV-FAIDS-61E or 105 infectious units green fluorescence of lymphocytes, and cells were
of FeLV-FAIDS-61E/C (Overbaugh et al., 1988). FeLV- sorted at less than 2000 cells per second with coinci-
FAIDS-61E/C is a mixture of the molecular clones 61E dence abort engaged. Cells were sorted into RPMI 1640
and 61C. Animals that were necropsied were eutha- medium with 50% fetal calf serum and kept on ice until
nized by intravenous barbiturate overdose. Animals reanalysis on an EPICS Profile II (Coulter Electronics,
used in the proviral burden assays were either acutely Hialeah, FL) to determine purity.
infected (12 – 15 weeks PI, n 6) or chronically infected
(41 – 165 weeks PI, n 6). Animals used in experiments Infection of cell lines
to determine the expression of FeLV were acutely in-
The feline T cell line 3201 (a gift from W. D. Hardy, Jr.,fected (6 – 21 weeks PI, n  13) or chronically infected
and E. E. Zuckerman, Memorial Sloan-Kettering Institute,(156 – 211 weeks PI, n  9).
New York, NY) (Snyder et al., 1978) was grown in 1:1
RPMI 1640:Leibovitz L-15 medium supplemented with
Cell isolation 15% FCS, 2% glutamine, and 1% penicillin-streptomycin.
The 3201 T cell line was infected with FeLV-FAIDS 61E
Peripheral blood mononuclear cells (PBMC) were iso- and the replication competent 61E-61C viral chimera,
lated from EDTA or heparinized blood by ficoll-hypaque EECC (Overbaugh et al., 1988), and supernatants were
gradient centrifugation as previously described (Quack- monitored for FeLV CA (p27 Gag) by antigen capture
enbush et al., 1989). The mononuclear cell layers were (Lutz et al., 1983). The FeLV-FAIDS 61E- and EECC-in-
harvested, washed four times with phosphate-buffered fected cells were cloned by limiting dilution.
saline (PBS), resuspended in lymphocyte medium com-
posed of RPMI 1640 supplemented with 10% fetal calf Cell lysate preparation and PCR amplification
serum (Hyclone Laboratories, Logan, UT), 2% glutamine,
and 1% penicillin-streptomycin, and enumerated. The One hundred thousand sorted lymphocytes were
added to microfuge tubes and washed with 1 ml PBS.mesenteric lymph node was collected in cold medium,
minced into small pieces, and processed through a wire The pellets were then resuspended in 50 ml of PCR lysis
buffer (45 mM NaCl, 9 mM Tris–HCl, pH 8.3, 2.2 mMmesh to obtain single cell suspensions. The cells were
washed four times with PBS, resuspended in the above MgCl2 , 0.1 mg/ml gelatin, 0.4% Nonidet P-40, 0.4% Tween
20, 1 mg/ml proteinase K). Tubes were placed in a 607medium, and enumerated.
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water bath for 12–15 hr, treated at 957 for 10 min, and al., 1995), or FITC conjugated polyclonal antibody to fe-
line IgG as described above. The FeMy antibody recog-frozen at 0207 until needed (Zack et al., 1992).
The PCR mixture consisted of 50 mM KCl, 10 mM Tris – nizes feline monocytes and granulocytes. After labeling
for the cell surface marker, cells were washed 21 withHCl (pH 8.3), 1.5 mM MgCl2 , 0.01% gelatin, 200 mM of
each dNTP, 10 pmol of each primer, and 2.5 units 1 ml PBS/FCS/NaN3 and fixed in 2% paraformaldehyde
in PBS at 47 for 30 min. Cells were washed 21 with 1Thermus aquaticus (Taq) polymerase. Twenty-five micro-
liters of cell lysate was added to each PCR reaction in ml PBS/FCS/NaN3 , resuspended in 70% methanol, and
incubated at 47 for 1 hr. Cells were washed and resus-a total of 100 ml, which was then overlaid with mineral
oil. Each amplification cycle consisted of 30 sec at 947, pended in 30 ml of phycoerythrin-conjugated monoclonal
antibody to FeLV p27 (A2) (Lutz et al., 1983). The cells20 sec at either 577 (TR1/Q1 primers) or 597 (TR3/Q1
primers), 20 sec at 727 for 30 cycles, followed by 1 cycle were incubated at 47 for 30 min, washed 21 with 1 ml
PBS/FCS/NaN3 , resuspended in PBS, and analyzed byat 727 for 5 min (Reinhart et al., 1993). Using the 61E
virus-specific primer, TR1 (nucleotide position 6260– flow cytometry.
6277) 5*AATGTAAAACACGGGGCA3* or the 61C virus-
Statisticsspecific primer, TR3 (nucleotide position based on the
61E sequence 6252–6259 / 6278–6287) 5*GCCCAA- Student’s t test was used for all statistical analyses. A
CCGGGTACCCTC3* with the Q1 primer (nucleotide posi- P value less than 0.05 was considered significant.
tion 6415–6397 based on the 61E sequence) 5*CCCATC-
TTGTGCCCCTCCA3*, either a 155-bp region of the FeLV
RESULTS
61E env gene or a 145-bp region of the FeLV 61C env
gene is amplified. Hematologic and lymphocyte subsets
Due to the nature of studies ongoing at the time theLiquid hybridization, detection, and quantitation
proviral burden assays used here were developed, the
Specific products were detected using solution hybrid- 61E-infected cats used were chronically infected [mean
ization of the 32P-labeled oligonucleotide probe Q32  123 { 45 weeks post infection (PI)], whereas the 61E/
(GGAAACCGGGGTCGCTCCCCCGTACAGGCCCCGT) C cats were in the early stage of infection (13 { 1 weeks
that hybridizes to a conserved region of the env gene of PI) (Table 1). While the total leukocyte counts of the 61E
both the 61E and 61C genome and is internal of the and 61E/C cats were not significantly different (mean 
primers used for amplification. The Q32 probe was end 5695 { 1335 cells/ml vs 6331 { 3145 cells/ml, respec-
labeled using a 5* end labeling kit (Boehringer Mann- tively), the lymphocyte counts of the 61E/C cats (1822 {
heim, Indianapolis, IN) according to manufacturer’s in- 973 cells/ml) were significantly lower than those of 61E
structions. cats (3344 { 1484 cells/ml). The lymphopenia in 61E/C-
PCR amplified products were phenol:chloroform ex- infected animals was due principally to significantly
tracted. Twenty microliters of amplified product and 10 lower CD4/ (mean  351 { 238 cells/ml vs 61E mean
ml of hybridization mixture (4 ml 60 mM NaCl, 0.8 ml 40 of 752 { 462 cells/ml) and CD8/ T cell numbers (mean
mM EDTA, 2.5 1 105 cpm Q32) were incubated at 957  215 { 114 cells/ml vs 61E mean of 757 { 414 cells/
for 5 min, and placed in a 567 water bath for 30 min ml) (Table 1). The number of IgG/ lymphocytes was not
(Kellogg and Kwok, 1990). Samples were subjected to significantly different between 61E and 61E/C cats (mean
electrophoresis in 10% acrylamide gels at 150 V for 4 hr,  1307 { 421 vs 983 { 723 cells/ml, respectively) (Table
fixed in 10% acetic acid, and exposed to film overnight. 1). Likewise, there were no significant differences in
Films were scanned with a Hewlett-Packard Scan Jet mean hematocrits, although two 61E/C-infected cats had
IIC. Densitometry was performed using the Scan Analy- low hematocrits (2821  10%, 2831  26%) (Table 1).
sis 6800 software (Biosoft). The OD/mm2 readings from Thus T cell lymphopenia distinguished cats infected with
the 61E-B10 or 61C-D9 samples were plotted generating FeLV-FAIDS 61E/C from those infected with 61E alone.
a standard curve that was used to interpolate the copy
Genome-specific proviral assaynumber of the experimental samples.
Clones of the feline T cell line 3201 containing eitherDual label for cell surface phenotype and intracellular
the 61E or 61C viral genome were established as stan-FeLV p27 antigen
dards for quantitation of proviral burden in lymphocyte
subsets from infected cats. Five 61E and eight 61CTo concurrently identify lymphocyte phenotype and in-
tracellular expression of FeLV CA, a method of sequential clones were derived by limiting dilution-cloning, of which
two clones (designated 61E-B10 and 61C-D9) were se-paraformaldehyde and methanol fixation was adapted
from Pollice et al. (1992). Five hundred thousand to one lected for further analysis. Southern blotting with an ex-
ogenous FeLV LTR-specific probe (FeLV ex-U3 LTR)million PBMC were labeled with either FITC-conjugated
monoclonal antibody to CD4, CD8, or FeMy (Groshek et (Mullins et al., 1981, 1986, 1991) was used to identify
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TABLE 1
Hematologic and Lymphocyte Subset Data
Mean Mean
No. of No. of Mean No. of Mean No. Mean No. Mean No.
weeks PI PCV Mean No. of total lymphs of total of Total of total IgG
Virus { SD { SD WBC { SD { SD CD4 { SD CD8 { SD { SD
61E 123 { 45 33 { 3 5695 { 1335 3344 { 1484 752 { 462 757 { 414 1307 { 421
Age-matched uninoculated
controls 34 { 4 na 4458 { 2121 1272 { 584 904 { 324 na
61E/C 13 { 1 29 { 10 6331 { 3145 1822 { 973 351 { 238 215 { 114 983 { 723
Age-matched uninoculated
controls 34 { 3 163381 { 2382 7221 { 2045 1617 { 636 795 { 291 na
Note. na, data not available.
clonal integration patterns and establish that the proviral sorted to ⁄97% purity by FACS. Both the 61E and 61C
viral genomes were detectable in each of the lymphocytecopy number (cc) was 2 cc/cell for the 61E-B10 clone
and 6 cc/cell in 61C-D9 cell clone (data not shown). By subsets from each of the cats; however, a large range
in proviral burden was detected.exploiting the 5* 18-bp deletion unique to the 61C SU,
two virus-specific primers (TR1 and TR3) were designed
(Reinhart et al., 1993) and virus-specific amplification was 61E provirus
demonstrated using lysates of 61E-B10 and 61C-D9 cells
61E-infected cats. The highest viral burden detectedas well as cells infected with the 61E/C virus inoculum
(mean  4.4 { 3.1 cc/cell) was in the IgG/ lymphocyte(Fig. 1). Densitometry readings from twofold dilutions of
population from the cats chronically infected with 61E61E-B10 and 61C-D9 lysates were used to generate a
(Fig. 4). The mean proviral load in the CD4/ T cellsstandard curve for each PCR reaction (Fig. 2). The provi-
of the same cats was 0.60 { 0.86 cc/cell. The CD8/ral burden in each purified lymphocyte subset population
subpopulation contained a mean of 0.74 { 0.67 cc/cell.was determined with the equation generated from the
Thus the average viral burden in the IgG/ lymphocytesstandard curves (Figs. 2C and 2D). A representative auto-
was five to seven times higher than that in the CD4/ orradiograph generated from a solution hybridization dem-
CD8/ cells.onstrating the 61E viral genome in CD4/, CD8/, and
61E/C-infected cats. The 61E mean proviral burden inIgG/ lymphocytes is in Fig. 3.
circulating CD4/ cells of 61E/C cats was 0.91 { 1.16
cc/cell, similar to that in 61E cats. In CD8/ cells theProviral burden in lymphocyte subpopulations
mean provirus load was slightly lower (0.27 { 0.19 cc/
CD4/, CD8/, and IgG/ blood and mesenteric lymph
cell) than that in 61E cats. By contrast, the 61E provirus
node lymphocytes from six 61E and six 61E/C cats were
load in the IgG/ (B) lymphocyte population was signifi-
cantly lower in 61E/C cats (0.34{ 0.21 cc/cell) compared
with 61E cats (Fig. 4). Thus, the virus burden in circulating
T cells of 61E/C cats was equivalent to that in 61E cats.
The 61E proviral copy number in lymph node T cells
was similar to that in circulating T cells: mean  0.86 {
1.00 vs 0.91 { 1.16 cc/cell in CD4/ cells and 0.35 {
0.31 vs 0.27 { 0.19 cc/cell in CD8/ cells, respectively
(Figs. 4 and 5). Although the 61E/C animals were ana-
lyzed early in infection (mean  91 { 8 days PI), their T
lymphocyte proviral load was similar to that seen in ani-
mals chronically infected with 61E (mean  861 { 317
days PI). The 61E proviral burden in lymph node IgG/
FIG. 1. PCR amplification using virus-specific primer pairs. Lysates cells from the 61E/C cats (2.53 { 2.11 cc/cell) was
from uninfected (U), 61E-B10 (E), 61C-D9(C), and 61E/C (E/C) infected greater than that in lymph node T cells (Fig. 5).
cells were subjected to PCR amplification with 61E-specific (TR1/Q1)
and 61C-specific (TR3/Q1) primers. The 61E-specific primers amplify a
61C provirus155-bp product while the 61C-specific primers amplify a 145-bp prod-
uct. Amplified products were hybridized in solution to the 32P-Q32 oligo-
The 61C viral DNA also was detected in the CD4/,nucleotide probe, subjected to electrophoresis, and exposed to film
overnight. CD8/, and IgG/ lymphocytes from both blood and
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FIG. 2. Semiquantitative PCR for FeLV-FAIDS 61E and 61C viral genomes in cloned cell lines. Cell lysates from the 61E-B10 (A) and 61C-D9 (B)
cell lines were subjected to PCR using virus-specific primers and amplified product was hybridized in solution with the Q32 probe. Autoradiographs
were scanned and densitometry readings used to generate a standard curve for each PCR reaction. The standard curves generated for the 61E-
B10 (C) and 61C-D9 (D) cell lines and the equation used for interpolation of the experimental samples are shown.
lymph node. The 61C proviral load was slightly lower and the variant (61C) viruses. Whereas the 61E viral bur-
den was similar in T cells isolated from chronically andthan that of 61E in circulating CD4/ (0.59 { 0.83 cc/cell)
and CD8/ (0.11 { 0.16 cc/cell) T cells of 61E/C-infected acutely infected animals, significantly more provirus re-
sided in IgG/ cells from the chronically infected cats.cats. 61C provirus levels (0.06{ 0.10 cc/cell) were signif-
icantly lower than those of 61E in circulating IgG/ lym- While the 61C burden in T cells approached that of 61E,
lower levels of the variant 61C provirus were detectedphocytes (Fig. 4). The 61C proviral burden in CD4/,
CD8/, and IgG/ lymph node cells (0.45 { 0.54, 0.29 { in the IgG/ B cell fraction.
0.47, and 0.13 { 0.16 cc/cell, respectively) was similar
to that found in circulating cells (Figs. 4 and 5). Virus expression in lymphocytes and other leukocytes
In summary, CD4/, CD8/, and IgG/ lymphocytes of infected cats
were infected by the FeLV-FAIDS common form (61E)
To identify lymphocyte and leukocyte populations
which replicate FeLV in vivo, blood mononuclear cells
(PBMC) from cats chronically infected with 61E (mean 
168 { 36 weeks PI) or acutely with 61E/C (mean  13 {
6 weeks PI) were simultaneously labeled for cell surface
phenotype and intracellular expression of FeLV CA (p27).
Two analysis regions, corresponding to lymphocytes and
monocytes plus large lymphocytes, were identified
based on light scatter characteristics (Fig. 6A). Dual la-
beling for cell phenotype and FeLV CA demonstrated that
a substantial fraction of CD4/ and CD8/ T cells, B cells,
and feline myeloid antigen-positive (FeMy/) monocytes
FIG. 3. Solution hybridization of 61E viral genome from cat 2253. and granulocytes expressed intracellular p27 (Figs. 6B
Cell lysates from purified CD4/, CD8/, and IgG/ lymphocytes were and 6C). Fifty-one to 59% of each lymphocyte subset (CD4
amplified with the 61E-specific primers and hybridized with the Q32
mean  51 { 20%; CD8 mean  59 { 23%; IgG meanprobe. A set of diluted lysates, equivalent to 200 cells, was amplified  55 { 23%) from 61E-infected cats were p27-positiveand the mean densitometry readings were used to quantitate the provi-
ral burden in each population. (Fig. 7). The mean percentages of CD4/, CD8/, and
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proviral sequences were amplified by semiquantitative
PCR exploiting an env deletion in 61C relative to 61E.
Concurrent surface and intracellular flow cytometric
analysis was used to identify productive infection of lym-
phocyte phenotypes.
These studies demonstrated that the target cells for
FeLV-FAIDS 61E (common form) and 61C (variant) vi-
ruses are abundant and include both T and B cells. The
highest initial FeLV burden was found in CD4/ T cells,
whereas the greatest viral burden in chronically infected
cats was present in circulating IgG/ B lymphocytes.
These studies were not designed to compare virus bur-
den in acute and chronically infected cats; however,
these results are consistent with earlier immunofluores-
cence studies localizing viral antigen primarily to
lymphoid follicles in cats infected with the FeLV-FAIDS
and FeLV-Rickard (FeLV-R) isolates (Hoover et al., 1987;
Rojko et al., 1979). The present study extends the earlier
work of Rojko et al. (1981) which associated FeLV princi-
pally with complement receptor-bearing cells in lymph
nodes of FeLV infected cats. Whereas immunofluores-
cence localization of FeLV CA in lymph node tissue sec-
tions could not exclude trapping of virus or viral antigen
by dendritic cells (Embretson et al., 1993; Fox et al., 1991;
Pantaleo et al., 1991), here we confirm that B cells are
extensively infected by the T cell depleting FeLV-FAIDS
isolate.
FIG. 4. 61E and 61C proviral burden in circulating lymphocyte sub- Both the FeLV-FAIDS 61E and 61C genomes were de-
sets from FeLV-FAIDS-infected cats. Each symbol represents the value tected in CD4/ and CD8/ T cells. This finding also
of the proviral burden in copies/cell of each individual cat analyzed.
supports the previous findings of Rojko et al. (1981) inThe bar represents the mean proviral burden in copies/cell of each
which cell separation via guinea pig erythrocyte rosettinggroup of animals (n  6 cats per group). The 61E genome is repre-
sented by the open symbols and the 61C genome as closed symbols. was used to demonstrate FeLV infection in T cells. The
Cell subsets are represented by h, CD40; L, CD80; and s, IgG0.
IgG/ lymphocytes expressing CA were not significantly
different.
In cats acutely infected with 61E/C, again all lympho-
cyte subsets expressed FeLV CA, albeit in lower fre-
quency (CD4 mean  24 { 10%; CD8 mean  18 { 9%)
than in 61E cats. The fraction of B cells infected was
equal to that in chronically infected animals (mean  54
{ 7%) (Fig. 7).
In both 61E and 61E/C cats virtually all cells that ex-
pressed the feline cell surface myeloid antigen FeMy
also expressed FeLV CA (mean  93 { 3% and 85 {
25%, respectively) (Fig. 7).
In summary, the high proviral load in cats infected with
61E and 61E/C was accompanied by high levels of viral
expression not only in a fraction (20–60%) of all three
major circulating lymphocyte subsets but also in nearly
FIG. 5. 61E and 61C proviral burden in lymph node cell subsets from
all (85–93%) monocytes. FeLV-FAIDS-infected cats. The 61E viral genome is represented by the
open symbols and the 61C genome by the closed symbols. Each sym-
bol represents the number of proviral copies/cell determined for anDISCUSSION
individual cat. The bar represents the mean proviral burden as number
We used two new methods to identify FeLV-FAIDS- of copies/cell of all cats (n  6). Cell subsets are represented by
symbols h, CD40; L, CD80; and s, IgG0.infected lymphocyte subsets in vivo. Genome-specific
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moiety is implicated as the receptor for the amphotropic
murine leukemia viruses (MuLV) (Miller et al., 1994),
whereas the ecotropic MuLV receptor has been identi-
fied as a basic amino acid transporter (Albritton et al.,
1989; Kim et al., 1991; Wang et al., 1991). Finally, the
studies of Reinhart et al. (1993) suggest that FeLV-FAIDS
61E and 61C use the same primary receptor or receptor
complex but may have different secondary receptor moi-
eties.
FeLV CA was detected in large fractions of CD4/,
CD8/, and IgG/ lymphocytes from both 61E- and 61E/
C-infected cats. The fraction of CA-positive T cells was
lower in acutely infected animals (13 weeks) whereas
50% of lymphocytes from chronically infected cats con-
tained viral antigen. The relatively low frequency of FeLV-
infected T cells early in infection is consistent with previ-
ous studies in FeLV-Rickard-infected cats (Rojko et al.,
1981, 1979). This could reflect cytopathic FeLV infection
of T cells early in the course of infection in vivo. Two
different groups of 61E/C-infected cats were used in the
proviral burden and virus expression assays which may
FIG. 6. Two color flow cytometric analysis of PBMC from FeLV-
FAIDS-infected cats. PBMC were isolated from 61E- and 61E/C-infected
cats, labeled for cell surface markers (CD4, CD8, IgG, or FeMy), fixed,
permeabilized, and stained with antibody against FeLV CA. Two regions
were analyzed (A); bitmap 1 represents cells that are predominantly
lymphocytes and bitmap 2 represents cells that are predominately
monocytes and large lymphocytes. B is representative of lymphocytes
analyzed within bitmap 1 that mark for either CD4, CD8, or IgG and
intracellular FeLV CA. C demonstrates analysis of bitmap 2, which
contains primarily myeloid cells (FeMy/) that express FeLV CA.
high proviral load in lymphocytes of FeLV-infected cats
contrasts with lentivirus infections in which a proviral
frequency of 1 in 100 to 10,000 PBMC is typical (Embret-
son et al., 1993, Graziosi et al., 1993; Pantaleo et al.,
1991, 1993). By contrast, the FeLV burden is at least
100 times greater (500 to 10,000 infected cells in 10,000
PBMC), and the mean FeLV genome equivalent (proviral
copy) per cell is often greater than 1. Using the genome-
specific proviral assay we are unable to distinguish be-
tween integrated and unintegrated viral DNA. It is there-
fore possible that those cells harboring high levels of
unintegrated variant virus and cytopathically infected
may have escaped purification and detection by these
assays.
Targeting of 61E and 61C to lymphocytes suggests that
FeLV uses a ubiquitous cell surface receptor molecule. A FIG. 7. FeLV CA expression in PBMC subsets from FeLV-FAIDS-
infected cats. Each symbol represents data from an individual cat. The70-kDa putative receptor molecule which binds the FeLV
closed symbols (A) are 61E-infected cats and the open symbols (B) aresubgroup A SU has been identified (Ghosh et al., 1992).
61E/C-infected cats. The horizontal bar represents the mean number ofOther work indicates that FeLV subgroup B viruses utilize
cells expressing FeLV CA for each group [n  9 (61E) or n  13 (61E/
a receptor similar to that used by gibbon ape leukemia C) in CD4, CD8, and FeMy subsets and n  5 (61E) or n  3 (61E/C)
virus (Takeuchi et al., 1992). This molecule is thought to in IgG lymphocytes]. Cell subsets are represented by the symbols: h,
CD40; n, CD80; s, IgG0; and L, FeMy.be a phosphate transporter (Johann et al., 1992). A similar
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